Contact
searchSearch
HMP Global

December 2017 - FRMC

Department

Conference Insider
Oncology Outlook: Cancer Drug Pipeline Focused on Precision Treatments
01/02/2018
David Costill
Spotlight on the Oncology Pipeline, a session at AMCP Nexus 2017, highlighted three recent and upcoming cancer drug approvals.
Spotlight on the Oncology Pipeline, a session at AMCP Nexus 2017, highlighted three recent and upcoming cancer drug approvals.
Spotlight on the Oncology...
01/02/2018
First Report Managed Care
Conference Insider
30-Day Medicare Spending for Acute Myocardial Infarction Varies Widely
01/02/2018
An investigation into 30-day Medicare spending among patients hospitalized with acute myocardial infarction (AMI) found that spending varies across hospitals
An investigation into 30-day Medicare spending among patients hospitalized with acute myocardial infarction (AMI) found that spending varies across hospitals
An investigation into 30-day...
01/02/2018
First Report Managed Care
Conference Insider
Study Finds Xarelto With Aspirin Reduced Direct Atherosclerotic Disease Costs
01/02/2018
Data from the COMPASS trial, presented at the AHA 2017 Scientific Sessions, found that a regimen of Xarelto (rivaroxaban; Janssen) with 100 mg of aspirin reduced hospitalization, and health services costs among patients with stable...
Data from the COMPASS trial, presented at the AHA 2017 Scientific Sessions, found that a regimen of Xarelto (rivaroxaban; Janssen) with 100 mg of aspirin reduced hospitalization, and health services costs among patients with stable...
Data from the COMPASS trial,...
01/02/2018
First Report Managed Care
Conference Insider
TAVR Does Not Significantly Reduce Mortality Compared With Surgery
01/02/2018
Data presented at the AHA 2017 Scientific Sessions found that all-cause mortality among patients undergoing transcatheter aortic valve replacement (TAVR) was not significantly different compared with patients undergoing surgical aortic valve...
Data presented at the AHA 2017 Scientific Sessions found that all-cause mortality among patients undergoing transcatheter aortic valve replacement (TAVR) was not significantly different compared with patients undergoing surgical aortic valve...
Data presented at the AHA 2017...
01/02/2018
First Report Managed Care
Conference Insider
Novel Cardiovascular Treatments Priced Too High
01/02/2018
A cost analysis of cardiovascular medications approved between 2011 and 2016 found that prices are dramatically disproportionate to the clinical benefit, according to a presentation at the AHA 2017 Scientific Sessions. 
A cost analysis of cardiovascular medications approved between 2011 and 2016 found that prices are dramatically disproportionate to the clinical benefit, according to a presentation at the AHA 2017 Scientific Sessions. 
A cost analysis of...
01/02/2018
First Report Managed Care
Conference Insider
Patient Assistance Program Improves Outcomes for Low-Income RA Patients
01/02/2018
Oftentimes treatment is inadequate due to issues with access to care or medication costs for uninsured patients with rheumatic disease. However, according to an abstract presented at the 2017 ACR/ARHP Annual Meeting, a patient assistance...
Oftentimes treatment is inadequate due to issues with access to care or medication costs for uninsured patients with rheumatic disease. However, according to an abstract presented at the 2017 ACR/ARHP Annual Meeting, a patient assistance...
Oftentimes treatment is...
01/02/2018
First Report Managed Care
Conference Insider
Health Coaching Intervention Improved Rheumatoid Arthritis Symptoms
01/02/2018
A poster presentation at the 2017 ACR/ARHP Annual Meeting found that implementing a digital health coaching program helped to improve healthy behaviors and reduce flare ups among patients with rheumatoid arthritis (RA).
A poster presentation at the 2017 ACR/ARHP Annual Meeting found that implementing a digital health coaching program helped to improve healthy behaviors and reduce flare ups among patients with rheumatoid arthritis (RA).
A poster presentation at the...
01/02/2018
First Report Managed Care
Conference Insider
Remicade Doses Increase Significantly Throughout Administration, Could Impact Costs
01/02/2018
A study comparing Simponi (golimumab) dosing changes over time to Remicade (infliximab) dosing changes over time found that Remicade doses increase significantly throughout the rheumatoid arthritis regimen administration, according to an...
A study comparing Simponi (golimumab) dosing changes over time to Remicade (infliximab) dosing changes over time found that Remicade doses increase significantly throughout the rheumatoid arthritis regimen administration, according to an...
A study comparing Simponi...
01/02/2018
First Report Managed Care
Conference Insider
New Care Model Improves Early PsA Diagnosis in Psoriasis Patients
01/02/2018
Due to a higher rate of undiagnosed psoriatic arthritis (PsA) in psoriasis patients, a new care model suggests that musculoskeletal (MSK) ultrasounds, triage questionnaires, and clinical assessments by an advanced practice physiotherapist...
Due to a higher rate of undiagnosed psoriatic arthritis (PsA) in psoriasis patients, a new care model suggests that musculoskeletal (MSK) ultrasounds, triage questionnaires, and clinical assessments by an advanced practice physiotherapist...
Due to a higher rate of...
01/02/2018
First Report Managed Care
Conference Insider
Multi-Biomarker Disease Activity Scores Significantly Impact Rheumatologists’ Decisions
01/02/2018
A poster presented at the 2017 ACR/ARHP Annual Meeting found that multi-biomarker disease activity (MBDA) score results significantly impacted decisions to switch therapy or add new therapies. 
A poster presented at the 2017 ACR/ARHP Annual Meeting found that multi-biomarker disease activity (MBDA) score results significantly impacted decisions to switch therapy or add new therapies. 
A poster presented at the 2017...
01/02/2018
First Report Managed Care

Behind the Bill

Behind the Bill
SCOTUS Takes on the Nondelegation Doctrine: Surprising Reactions and What They Mean for Agency Power
04/02/2025
Katie Hayes, MJ
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard...
04/02/2025
First Report Managed Care
Behind the Bill
Dr Oz’s Prescription for Making Medicaid “Viable at Every Level”
03/26/2025
Katie Hayes, MJ
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the...
03/26/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question Continues: Dr Oz's Confirmation and the Future of Medicaid
03/19/2025
Katie Hayes, MJ
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880...
03/19/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question: Can Congress Cut Spending Without Touching Medicaid?
03/12/2025
Katie Hayes, MJ
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from...
03/12/2025
First Report Managed Care
Behind the Bill
RFK Jr’s Public Comment Ban: The Silent Shift in Health Care Rulemaking
03/05/2025
Katie Hayes, MJ
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative...
03/05/2025
First Report Managed Care
Behind the Bill
Prevention Over Pills? The First 2 Weeks of Health Care’s New Direction
02/26/2025
Katie Hayes, MJ
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from...
02/26/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 2)
02/19/2025
Katie Hayes, MJ
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the...
02/19/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 1)
02/12/2025
Katie Hayes, MJ
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust...
02/12/2025
First Report Managed Care
Behind the Bill
No, President Trump Did Not Actually Sign an Executive Order That Would Increase Drug Costs for Beneficiaries
02/05/2025
Katie Hayes, MJ
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President...
02/05/2025
First Report Managed Care
Behind the Bill
Robert F. Kennedy Jr’s Confirmation and the Unexpected Turn in the Drug Pricing Debate
01/29/2025
Katie Hayes, MJ
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug...
01/29/2025
First Report Managed Care

Subscribe and Stay Ahead With Daily Industry Insights

First Report Managed Care Newsletter

Trending Articles

Headshot of Gary Owens
Interview
An Overview of Vitiligo: Prevalence, Comorbidities, and Available Therapies
05/30/2023
Maria Asimopoulos
Gary Owens, MD, president of Gary Owens Associates, reviews the prevalence and burden associated with vitiligo as well as coverage considerations for a range of treatment options. 
Gary Owens, MD, president of Gary Owens Associates, reviews the prevalence and burden associated with vitiligo as well as coverage considerations for a range of treatment options. 
Gary Owens, MD, president of...
05/30/2023
First Report Managed Care
News
Substantial Annual Health Care Costs Associated With Hemophilia A
06/23/2023
Julie Gould
Researchers conducted a comprehensive literature review to investigate the direct and indirect costs associated with hemophilia A.
Researchers conducted a comprehensive literature review to investigate the direct and indirect costs associated with hemophilia A.
Researchers conducted a...
06/23/2023
First Report Managed Care
News
RSV Vaccination in US Older Adults Could Save Up to $1 Billion Per Season
07/24/2023
Jolynn Tumolo
"Our analysis provides contemporary estimates of the population-level RSV disease burden and insights into the economic value drivers for RSV vaccination," said researchers. 
"Our analysis provides contemporary estimates of the population-level RSV disease burden and insights into the economic value drivers for RSV vaccination," said researchers. 
"Our analysis provides...
07/24/2023
First Report Managed Care
News
Hospital-Onset CDI Incidence, Antibiotic Use Drop With Two-Step Testing
08/16/2023
Jolynn Tumolo
The implementation of two-step testing for Clostridioides difficile infection may lead to a decrease in hospital-onset CDI and antibiotic use, suggesting improved diagnostic specificity and indirect reassurance against underdiagnosis and...
The implementation of two-step testing for Clostridioides difficile infection may lead to a decrease in hospital-onset CDI and antibiotic use, suggesting improved diagnostic specificity and indirect reassurance against underdiagnosis and...
The implementation of two-step...
08/16/2023
First Report Managed Care

December 2017 Volume 14 Issue 12

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use